急性心力衰竭症候群患者耗费了大量的医疗资源,对其本人、家庭和社会带来了巨大的经济负担。在传统药物基础上,利钠肽、醛固酮受体拮抗剂、钙增敏及钾通道开放剂、内皮素和血管加压素拮抗剂等新药的应用对于这类患者治疗疗效的提高引起了广泛的关注。现对此作一简单介绍。 Patients suffering from acute heart failure syndrome consume a large amount of medical resources and bring huge financial burden to themselves, their families and society. On the basis of conventional drugs, the use of new drugs such as natriuretic peptides, aldosterone receptor antagonists, calcium sensitizers and potassium channel openers, endothelin and vasopressin antagonists has led to a wide range of therapeutic benefits in such patients attention. Now make a brief introduction to this.